"Through this agreement, we acquired exclusive U.S. distribution rights to Dilon's HEMOBLAST Bellows product" and "gives us entry into an estimated $2 billion global addressable market for hemostatic ...
USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), an emerging global leader in rare earths, today announced its financial and operational results for the first quarter ended March 31, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results